Possible antimigraine mechanisms of action of the 5HT(1F) receptor agonist LY334370

Cephalalgia

Volumn 19, Issue 10, 1999, Pages 851-858

  Shepheard, S ^a   Edvinsson, L ^b   Cumberbatch, M ^a   Williamson, D ^a   Mason, G ^a   Webb, J ^a   Boyce, S ^a   Hill, R ^a   Hargreaves, R ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5HT(1F) receptor; LY334370; Migraine; Trigeminal

Indexed keywords

5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; CARRAGEENAN; SEROTONIN 1A AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERY; BRAIN BLOOD VESSEL; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; HUMAN; HUMAN TISSUE; HYPERALGESIA; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; RAT; VASODILATATION;

EID: 0033383070     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.1910851.x     Document Type: Article

References (36)

1. Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993;14:129-33
2. 1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs. Neuroreport 1997;8:2237-40
3. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99:202-6
4. 1F receptor agonist. Cephalalgia 1997;17:398
5. 1F agonist. Proceedings of the Migraine Trust Meeting, 1-4 September, London, 1998:64
6. 1F receptor agonist (SSOFRA) LY334370. Cephalalgia 1999;19:318
7. Hargreaves RJ, Williamson DJ, Shepheard SL. Neurogenic inflammation: relation to novel antimigraine drugs. In: Edvinsson L, editor. Migraine and headache pathophysiology. London: Martin Dunitz, 1999:93-103
8. Pappagallo M, Szabo Z, Esposito G, Lokesh A, Velez L. Imaging neurogenic inflammation in patients with migraine headaches. Neurology 1999;52:A274
9. Nissila M, Parkkola R, Sonninen P, Salonen R. Intracerebral arteries and gadolinium enhancement in migraine without aura. Cephalalgia 1996;16:363
10. Villalon C, De Vries P, Saxena PR. Serotonin receptors as cardiovascular targets. Drug Discovery Today 1997;2:294-300
11. Humphrey PPA, Feniuk W. Mode of action of the antimigraine drug sumatriptan. Trends Pharmacol Sci 1991;12:444-6
12. 1F receptor agonists LY334370 and LY344864 in the rabbit saphenous vein (RSV), a model for coronary and cerebral vasoconstrictor activity. Proceedings of the 4th IUPHAR satellite meeting on Serotonin, 23-25 July, 1998, Rotterdam. P38
13. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterising cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
14. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetised rat-intravital microscope studies. Cephalalgia 1997;17:525-31
15. 1F agonist, inhibits the central and peripheral projections of rat trigeminal sensory neurones. Society for Neuroscience abstracts 1998;24:639.13
16. 1F receptors in the human brain suggests a role in migraine. Cephalalgia 1997;17:341
17. 1F receptor subtype: a comparison of the pharmacological profile to the human species homolog. Neuropharmacology 1996;36:569-76
18. 3H]LY334370. Cephalalgia 1997;17:397
19. Jansen-Olesen I, Ottosson A, Cantera L, Strunk S, Lassen LH, Olesen J, et al. Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1 and H2 receptors by RT-PCR. Br J Pharmacol 1997;121:41-8
20. Cumberbatch MJ, Hill RG, Hargreaves RJ. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol 1997;328:37-40
21. Boyce S, Chan CC, Gordon R, Li CS, Rodger IW, Webb JK, et al. L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology 1994;33:1609-11
22. Zimmerman. Ethical guidelines for investigations on experimental pain in conscious animals. Pain 1983;16:109-10
23. 1F receptor activation. Br J Clin Pharmacol 1999;47:75-82
24. Nilsson T, Longmore J, Dhaw D, Pantev E, Bard JA, Branchek T, et al. Characterisation of 5HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 1999;372:49-56
25. 1F receptor agonist, in the neurogenic dural inflammation model of migraine pain. Soc Neurosci Abstr 1996;22:528.11
26. 1B/1D receptor agonists on neurogenic plasma extravasation and vasodilation in anaesthetised rats. Neuropharmacology 1997;36:525-33
27. 1F receptor binding sites in the guinea-pig brain: an autoradiographic study. NS Arch Pharmacol 1995;352:263-75
28. Shepheard SL, Williamson DJ, Hill RG, Hargreaves RJ. The non-peptide neurokinin1 receptor antagonist, RP67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol 1993;108:11-12
29. Lee Y, Kawai Y, Shiosaka S, Takami K, Kiyama H, Hillyard CJ, et al. Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis. Brain Res 1985;330:194-6
30. Messlinger K, Hanesch U, Baumgartel M, Trost B, Schmidt RF. Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol 1993;188:219-37
31. Edvinsson L, Hara H, Uddman R. Retrograde tracing of nerve fibres to the rat middle cerebral artery with true blue: co-localisation with different peptides. J Cereb Blood Flow Metab 1989;9:212-8
32. Uddman R, Edvinsson L, Ekman R, McCulloch J, Kingman T. Innervation of the feline cerebral vasculature by nerve fibres containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985;62:131-6
33. Uddman R, Hara H, Edvinsson L. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst 1989;26:69-75
34. Clements JR, Beitz AJ. An electron microscopic description of glutamate-like immunoreactive axon terminal in the principle sensory and spinal trigeminal nuclei. J Comp Neurol 1991;309:271-80
35. Kai-Kai MA, Howe R. Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia and intraspinal neurones and fibres in the dorsal horn of the rat. Histochem J 1991;23:171-9
36. 1 receptor antagonists L-733,060 and CP-99,994 and morphine in the rabbit spinal reflex preparation. Br J Pharmacol 1996;117:242P